ClinicalTrials.gg
Active, not recruitingNCT07064941Updated Jul 22, 2026

Effect of Exercise on Body Composition and Bone Health in Patients With Thalassemia

An interventional study of Exercise in Thalassemia, sponsored by University of California, San Francisco. Active, not recruiting at 2 sites in United States. Open to participants aged 14 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Dec 2024, registered Jul 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
14 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 104 studies in Thalassemia with a site in United States — 9 open to participants now, 20 under way, 8 of them phase 3. Thalassemia · United States.

Planned enrollment
48th of 81
20 · median 24
Started
2024
with 2 others
No phase
12 of 104
none open now
Primary completion
2026-12
later than 6 of 19 live
Registered
102nd of 104
by date
Lead sponsor
6 of 104
University of California, San Francisco

Among the 104 studies in Thalassemia with a site in United States, this one is the 48th largest by planned enrollment of the 81 interventional ones that give a count, is one of 3 that started in 2024, is one of 12 with no phase, reaches primary completion later than 6 of the 19 other live ones, and was the 102nd registered.

Thalassemia

252 studies on the registry are indexed under Thalassemia; 45 are open to participants now.

Browse Thalassemia studies →

Open to participants now

9 of the 104 studies in Thalassemia with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 29 Thalassemia studies recruiting now, 8 (28%) set no upper age limit and 18 (62%) stop at 75 or younger; 22 take children under 18; none take healthy volunteers.

This study: 14 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 104 studies in Thalassemia with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to determine if a weight bearing exercise intervention can improve body composition and bone health in adolescents and adults with Thalassemia.

The main questions it aims to answer are:

  • Does participation in a 12-week weight bearing exercise intervention change total body lean mass and percentage body fat (as assessed by DXA) in adolescents and adults with Thalassemia?
  • Does participation in a 12-week weight bearing exercise intervention change muscle function (assessed by hand grip strength, sit to stand and vertical jump) and endurance (assessed by the 6 minute walk test) in adolescents and adults with Thalassemia?
  • Does participation in a 36 week weight bearing exercise intervention (30 min/day; 5x/week) change bone mineral density as assessed by DXA in adolescents and adults with Thalassemia?

Researchers will compare participants' change in body composition, muscle mass, and muscle function during a "Usual Activity" period (12 weeks) with an exercise intervention (Period 1: 12 weeks) to see if exercise can improve body composition and muscle function.

The intervention will then be extended an additional 24 weeks for a total of 36 weeks of exercise (Period 2) to explore the change in bone mineral density between between "Usual Activity" and "Exercise Intervention" (Period 2) in individuals with Thalassemia.

During the intervention period, participants will engage in a self-directed exercise regime of either weight bearing aerobic exercise or strength training exercises (30 min/day; 5x/week).

03

Conditions studied

  • Thalassemia

Keywords

  • Exercise
  • Body composition
  • Bone
  • Muscle function
04

Who can participate

Ages eligible
14 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: 14 - 40 years
  • BMD Z-score at any skeletal site \< -1.0
  • Diagnosed with thalassemia (any genotype, regardless of transfusion dependency)
  • Vitamin D (25-Hydroxy) drawn within the previous 12 months >20 ng/mL
  • English speaking, able to consent

Exclusion criteria

Exclusion Criteria:

  • Patients who self-identify as 'exercisers' e.g. routinely exercise for minimum of 45 min/day, 5x/week
  • Pregnant (unable to conduct bone density measurements in pregnant females)
  • Hypogonadal, must be on replacement sex hormone therapy for min of 6 months
  • Cardiac T2* by Magnetic Resonance Imaging of \<20 ms (e.g. evidence of cardiac iron overload)
  • Recent long bone or vertebral fracture (within the last 6 months)
  • Cognitive impairment limiting ability to understand instructions during orientation
  • Other conditions known to influence bone health or body composition as determined by the investigator
  • Patients at risk for cardiovascular disease yet have not received a routine cardiology assessment within the previous 12 months
  • Bone medication (e.g. Zometa, Prolia, Forteo) use in previous 2 years
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Other
    Usual Activity

    Subjects will participate in usual daily activities during this period

    Behavioral: Exercise

Interventions

  • BehavioralExercise

    Exercise for 30 min a day 5x a week with a choice between Aerobic or strength training. Subjects will choose an aerobic activity to perform 3x/week (e.g. brisk walking, hiking, jogging). They will start at 15-20 min/day depending on fitness level and build up by 5 min intervals/week as tolerated to 50 min/day or 150 min/week by 12 weeks. Subjects will choose strength exercises to perform 2x/week, on days separate from aerobic activity. They will start with 1-2 exercises (e.g. squats, lunges, planks with and without resistance) and gradually add exercises to include all muscle groups (arms, legs, chest, back, abdomen). Start with 2 sets of 10 reps, and work up to 3 sets of 15 reps of given exercises.

06

What researchers measure

Primary outcomes

  1. Total Body Lean Mass (grams)

    Total body lean mass assessed by Dual Energy X-Ray Absorptiometry (DXA)

    Time frame: 12 weeks (Period 1) and 36 weeks (Period 2)

  2. Percentage Body Fat

    Percentage body fat assessed by Dual Energy X-Ray Absorptiometry (DXA)

    Time frame: 12 weeks (Period 1) and 36 weeks (Period 2)

Secondary outcomes

  1. 6 minute walk test (6MWT)

    Distanced walked during a 6MWT

    Time frame: 12 weeks (Period 1) and 36 weeks (Period 2)

  2. Vertical Jump

    Vertical jump from a standing height (cm)

    Time frame: 12 weeks (Period 1) and 36 weeks (Period 2)

  3. Bone Mineral Density (BMD)

    Bone mineral density at the spine, left hip, left distal radius and whole body as assessed by Dual Energy X-Ray Absorptiometry (DXA)

    Time frame: 36 weeks (Period 2)

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Dec 2026, 24 months after the start.

Of 18 interventional studies with no phase under Thalassemia, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 87. This study's planned 24 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 7, 2025
First posted
Jul 15, 2025
StartActual
Dec 1, 2024
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Jul 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07064941
Responsible party
Sponsor
First posted
Jul 15, 2025
Start date
Dec 1, 2024
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Jul 22, 2026

Study contacts

Ellen Fung, PhD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion